Global Endocrine Disruptor Assessment Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06253192

Publication Date:

June 19, 2025

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Endocrine Disruptor Assessment market size is predicted to grow from US$ 204 million in 2025 to US$ 302 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.
Endocrine Disruptor Assessment is the process of evaluating chemicals or substances for their potential to interfere with the endocrine system, which regulates hormones in living organisms. This assessment involves a combination of in vitro (laboratory-based), in vivo (animal-based), and computational methods to identify substances that may mimic, block, or alter hormonal functions, leading to adverse health effects such as reproductive issues, developmental disorders, or metabolic imbalances.
United States market for Endocrine Disruptor Assessment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Endocrine Disruptor Assessment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Endocrine Disruptor Assessment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Endocrine Disruptor Assessment players cover Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淓ndocrine Disruptor Assessment Industry Forecast鈥� looks at past sales and reviews total world Endocrine Disruptor Assessment sales in 2024, providing a comprehensive analysis by region and market sector of projected Endocrine Disruptor Assessment sales for 2025 through 2031. With Endocrine Disruptor Assessment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endocrine Disruptor Assessment industry.
This Insight Report provides a comprehensive analysis of the global Endocrine Disruptor Assessment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Endocrine Disruptor Assessment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Endocrine Disruptor Assessment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endocrine Disruptor Assessment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endocrine Disruptor Assessment.
This report presents a comprehensive overview, market shares, and growth opportunities of Endocrine Disruptor Assessment market by product type, application, key players and key regions and countries.
Segmentation by Type:
In Vitro (Cell-based) Testing
In Vivo (Animal) Testing
In Silico (Computational) Modeling
Others
Segmentation by Application:
Environmental Monitoring
Food Safety
Cosmetics and Personal Care Products
Public Health and Disease Prevention
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Labcorp
Eurofins Scientific
PerkinElmer
Intertek
Smithers
LAUS
Xenometrix
ToxStrategies
Fera Science
Compliance Services International
Staphyt
Creative Proteomics
Creative Bioarray

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endocrine Disruptor Assessment Market Size (2020-2031)
2.1.2 Endocrine Disruptor Assessment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Endocrine Disruptor Assessment by Country/Region (2020, 2024 & 2031)
2.2 Endocrine Disruptor Assessment Segment by Type
2.2.1 In Vitro (Cell-based) Testing
2.2.2 In Vivo (Animal) Testing
2.2.3 In Silico (Computational) Modeling
2.2.4 Others
2.3 Endocrine Disruptor Assessment Market Size by Type
2.3.1 Endocrine Disruptor Assessment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Endocrine Disruptor Assessment Market Size Market Share by Type (2020-2025)
2.4 Endocrine Disruptor Assessment Segment by Application
2.4.1 Environmental Monitoring
2.4.2 Food Safety
2.4.3 Cosmetics and Personal Care Products
2.4.4 Public Health and Disease Prevention
2.4.5 Others
2.5 Endocrine Disruptor Assessment Market Size by Application
2.5.1 Endocrine Disruptor Assessment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Endocrine Disruptor Assessment Market Size Market Share by Application (2020-2025)
3 Endocrine Disruptor Assessment Market Size by Player
3.1 Endocrine Disruptor Assessment Market Size Market Share by Player
3.1.1 Global Endocrine Disruptor Assessment Revenue by Player (2020-2025)
3.1.2 Global Endocrine Disruptor Assessment Revenue Market Share by Player (2020-2025)
3.2 Global Endocrine Disruptor Assessment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Endocrine Disruptor Assessment by Region
4.1 Endocrine Disruptor Assessment Market Size by Region (2020-2025)
4.2 Global Endocrine Disruptor Assessment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Endocrine Disruptor Assessment Market Size Growth (2020-2025)
4.4 APAC Endocrine Disruptor Assessment Market Size Growth (2020-2025)
4.5 Europe Endocrine Disruptor Assessment Market Size Growth (2020-2025)
4.6 Middle East & Africa Endocrine Disruptor Assessment Market Size Growth (2020-2025)
5 Americas
5.1 Americas Endocrine Disruptor Assessment Market Size by Country (2020-2025)
5.2 Americas Endocrine Disruptor Assessment Market Size by Type (2020-2025)
5.3 Americas Endocrine Disruptor Assessment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endocrine Disruptor Assessment Market Size by Region (2020-2025)
6.2 APAC Endocrine Disruptor Assessment Market Size by Type (2020-2025)
6.3 APAC Endocrine Disruptor Assessment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Endocrine Disruptor Assessment Market Size by Country (2020-2025)
7.2 Europe Endocrine Disruptor Assessment Market Size by Type (2020-2025)
7.3 Europe Endocrine Disruptor Assessment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Endocrine Disruptor Assessment by Region (2020-2025)
8.2 Middle East & Africa Endocrine Disruptor Assessment Market Size by Type (2020-2025)
8.3 Middle East & Africa Endocrine Disruptor Assessment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Endocrine Disruptor Assessment Market Forecast
10.1 Global Endocrine Disruptor Assessment Forecast by Region (2026-2031)
10.1.1 Global Endocrine Disruptor Assessment Forecast by Region (2026-2031)
10.1.2 Americas Endocrine Disruptor Assessment Forecast
10.1.3 APAC Endocrine Disruptor Assessment Forecast
10.1.4 Europe Endocrine Disruptor Assessment Forecast
10.1.5 Middle East & Africa Endocrine Disruptor Assessment Forecast
10.2 Americas Endocrine Disruptor Assessment Forecast by Country (2026-2031)
10.2.1 United States Market Endocrine Disruptor Assessment Forecast
10.2.2 Canada Market Endocrine Disruptor Assessment Forecast
10.2.3 Mexico Market Endocrine Disruptor Assessment Forecast
10.2.4 Brazil Market Endocrine Disruptor Assessment Forecast
10.3 APAC Endocrine Disruptor Assessment Forecast by Region (2026-2031)
10.3.1 China Endocrine Disruptor Assessment Market Forecast
10.3.2 Japan Market Endocrine Disruptor Assessment Forecast
10.3.3 Korea Market Endocrine Disruptor Assessment Forecast
10.3.4 Southeast Asia Market Endocrine Disruptor Assessment Forecast
10.3.5 India Market Endocrine Disruptor Assessment Forecast
10.3.6 Australia Market Endocrine Disruptor Assessment Forecast
10.4 Europe Endocrine Disruptor Assessment Forecast by Country (2026-2031)
10.4.1 Germany Market Endocrine Disruptor Assessment Forecast
10.4.2 France Market Endocrine Disruptor Assessment Forecast
10.4.3 UK Market Endocrine Disruptor Assessment Forecast
10.4.4 Italy Market Endocrine Disruptor Assessment Forecast
10.4.5 Russia Market Endocrine Disruptor Assessment Forecast
10.5 Middle East & Africa Endocrine Disruptor Assessment Forecast by Region (2026-2031)
10.5.1 Egypt Market Endocrine Disruptor Assessment Forecast
10.5.2 South Africa Market Endocrine Disruptor Assessment Forecast
10.5.3 Israel Market Endocrine Disruptor Assessment Forecast
10.5.4 Turkey Market Endocrine Disruptor Assessment Forecast
10.6 Global Endocrine Disruptor Assessment Forecast by Type (2026-2031)
10.7 Global Endocrine Disruptor Assessment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Endocrine Disruptor Assessment Forecast
11 Key Players Analysis
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Information
11.1.2 Charles River Laboratories Endocrine Disruptor Assessment Product Offered
11.1.3 Charles River Laboratories Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Charles River Laboratories Main Business Overview
11.1.5 Charles River Laboratories Latest Developments
11.2 Labcorp
11.2.1 Labcorp Company Information
11.2.2 Labcorp Endocrine Disruptor Assessment Product Offered
11.2.3 Labcorp Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Labcorp Main Business Overview
11.2.5 Labcorp Latest Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Information
11.3.2 Eurofins Scientific Endocrine Disruptor Assessment Product Offered
11.3.3 Eurofins Scientific Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Eurofins Scientific Main Business Overview
11.3.5 Eurofins Scientific Latest Developments
11.4 PerkinElmer
11.4.1 PerkinElmer Company Information
11.4.2 PerkinElmer Endocrine Disruptor Assessment Product Offered
11.4.3 PerkinElmer Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 PerkinElmer Main Business Overview
11.4.5 PerkinElmer Latest Developments
11.5 Intertek
11.5.1 Intertek Company Information
11.5.2 Intertek Endocrine Disruptor Assessment Product Offered
11.5.3 Intertek Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Intertek Main Business Overview
11.5.5 Intertek Latest Developments
11.6 Smithers
11.6.1 Smithers Company Information
11.6.2 Smithers Endocrine Disruptor Assessment Product Offered
11.6.3 Smithers Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Smithers Main Business Overview
11.6.5 Smithers Latest Developments
11.7 LAUS
11.7.1 LAUS Company Information
11.7.2 LAUS Endocrine Disruptor Assessment Product Offered
11.7.3 LAUS Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 LAUS Main Business Overview
11.7.5 LAUS Latest Developments
11.8 Xenometrix
11.8.1 Xenometrix Company Information
11.8.2 Xenometrix Endocrine Disruptor Assessment Product Offered
11.8.3 Xenometrix Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Xenometrix Main Business Overview
11.8.5 Xenometrix Latest Developments
11.9 ToxStrategies
11.9.1 ToxStrategies Company Information
11.9.2 ToxStrategies Endocrine Disruptor Assessment Product Offered
11.9.3 ToxStrategies Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 ToxStrategies Main Business Overview
11.9.5 ToxStrategies Latest Developments
11.10 Fera Science
11.10.1 Fera Science Company Information
11.10.2 Fera Science Endocrine Disruptor Assessment Product Offered
11.10.3 Fera Science Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Fera Science Main Business Overview
11.10.5 Fera Science Latest Developments
11.11 Compliance Services International
11.11.1 Compliance Services International Company Information
11.11.2 Compliance Services International Endocrine Disruptor Assessment Product Offered
11.11.3 Compliance Services International Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Compliance Services International Main Business Overview
11.11.5 Compliance Services International Latest Developments
11.12 Staphyt
11.12.1 Staphyt Company Information
11.12.2 Staphyt Endocrine Disruptor Assessment Product Offered
11.12.3 Staphyt Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Staphyt Main Business Overview
11.12.5 Staphyt Latest Developments
11.13 Creative Proteomics
11.13.1 Creative Proteomics Company Information
11.13.2 Creative Proteomics Endocrine Disruptor Assessment Product Offered
11.13.3 Creative Proteomics Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Creative Proteomics Main Business Overview
11.13.5 Creative Proteomics Latest Developments
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Information
11.14.2 Creative Bioarray Endocrine Disruptor Assessment Product Offered
11.14.3 Creative Bioarray Endocrine Disruptor Assessment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Creative Bioarray Main Business Overview
11.14.5 Creative Bioarray Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂